Category: Elderly
Italy: It’s the second highest Covid peak ever
Covid-19 infections in Italy are 100 times greater than one year ago.
More...France: BA.5 now dominant, Covid cases up by more than 50% in one week
BA.5 at 59%, sharp increase in Covid cases in all regions and age groups, hospital admission rate rising. More...
Nature: Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2
Following the hypothesis that some neurological symptoms of COVID-19 may also follow an amyloid etiology we identified two peptides from the SARSCoV-2 proteome that self-assemble into amyloid assemblies. More...
Germany: BA.5 now dominant with 50% of sequences
RKI: “The proportion of the omicron subline BA.5 was 50% in week 23, it has become the dominant variant. More...
France: BA.5 at 41% of sequences in week 24, 2022
“Progressive replacement of BA.2 by BA.5 with a strong increase in detection (41%), increased presence of the mutation at position L452 in screening (64% in week 24 vs 47% in week 23), linked to the increase of certain Omicron sub-lineages including BA.4 and BA.5.” More...
Pfizer: Paxlovid not effective in reducing symptoms in standard risk patients
Pfizer: “An updated analysis from 1,153 patients showed a non-significant 51% relative risk reduction”. More...
CDC: A quarter of elderly Covid survivors may have ongoing symptoms
CDC: “One in five COVID-19 survivors aged 18–64 years and one in four survivors aged ≥65 years experienced at least one incident condition that might be attributable to previous COVID-19. More...
WHO: China’s zero-Covid strategy is unsustainable *1 update*
China’s flagship zero-Covid strategy to defeat the pandemic is unsustainable, the World Health Organization said Tuesday, adding that it had told Beijing so and called for a policy shift. More...
Shielding “would not have been a viable public health strategy for COVID-19”
Shielding the vulnerable while allowing infections to spread among the wider population would not have been a viable public health strategy for COVID-19 and is unlikely to be effective for future pandemics. More...
France: Persistent Alpha variant infection in immunosuppressed patient in 2022
“We describe persistent circulation of SARS-CoV-2 Alpha variant in an immunosuppressed patient in France during February 2022. More...